摘要
千金藤素是来自传统中药千金藤的一种生物碱,是双苄基异喹啉生物碱家族的一员,临床中主要用于白细胞减少症等疾病。近来,千金藤素抗新冠病毒的研究受到广泛关注,作为千金藤素抗新冠病毒作用的原创发现者,我们简要总结了千金藤素抗新冠病毒的重要研究进展,包括千金藤素抗新冠病毒活性的发现和验证,千金藤素抗新冠病毒机制研究进展以及临床试验进展。
As a member of the dibenzyl isoquinoline alkaloid family,cepharathine is an alkaloid from the traditional Chinese medicine cepharathine,which is mainly used for treatment of leukopenia and other diseases.Recent studies of the inhibitory effect of cepharathine against SARS-CoV-2 have attracted widespread attention and aroused heated discussion.As the original discoverer of the anti-SARS-CoV-2 activity of cepharanthine,here we briefly summarize the discovery of cepharanthine and review important progress in relevant studies concerning the discovery and validation of anti-SARS-CoV-2 activity of cepharathine,its antiviral mechanisms and clinical trials of its applications in COVID-19 therapy.
作者
范华昊
刘珂
洪碧霞
何诗婷
韩鹏军
李卯晨
王姝琦
童贻刚
FAN Huahao;LIU Ke;HONG Bixia;HE Shiting;HAN Pengjun;LI Maochen;WANG Shuqi;TONG Yigang(College of Life Science and Technology,Beijing University of Chemical Technology,Beijing 100029,China;Beijing Advanced Innovation Center for Soft Matter Science and Engineering,Beijing University of Chemical Technology,Beijing 100029,China)
出处
《南方医科大学学报》
CAS
CSCD
北大核心
2022年第6期955-956,F0003,共3页
Journal of Southern Medical University
基金
国家重点研究与发展计划(2019YFC1200502,2020YFA0712102,BWS21J025,20SWAQK22)
国家自然科学基金(82151224)
中央高校基本科研业务费(BUCTZY2022)
健合集团全球研究与技术中心项目(H2021028)。
关键词
千金藤素
新冠病毒
研究进展
cepharanthine
SARS-CoV-2
research progress